These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 55397)
1. Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti-tumour antibodies. Ran M; Klein G; Witz IP Int J Cancer; 1976 Jan; 17(1):90-7. PubMed ID: 55397 [TBL] [Abstract][Full Text] [Related]
2. Tumor bound immunoglobulins: the relationship between the in vivo coating of tumor cells by potentially cytotoxic anti-tumor antibodies, and the expression of immune complex receptors. Braslawsky G; Ran M; Witz IP Int J Cancer; 1976 Jul; 18(1):116-21. PubMed ID: 947858 [TBL] [Abstract][Full Text] [Related]
3. Serologically detectable specific and cross-reactive antigens on the membrane of a polyoma virus-induced murine tumor. Witz IP; Lee N; Klein G Int J Cancer; 1976 Aug; 18(2):243-9. PubMed ID: 60289 [TBL] [Abstract][Full Text] [Related]
4. Murine natural anti-tumor antibodies. I. Rapid in vivo binding of natural antibody by tumor cells in syngeneic mice. Wolosin LB; Greenberg AH Int J Cancer; 1979 Apr; 23(4):519-29. PubMed ID: 437926 [TBL] [Abstract][Full Text] [Related]
5. Lymphocytotoxic autoantibodies eluted from in vivo propagating sarcoma cells of mice. Ran M; Yaakubowicz M; Witz IP J Natl Cancer Inst; 1978 Jun; 60(6):1509-13. PubMed ID: 206714 [TBL] [Abstract][Full Text] [Related]
6. Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas. Fritze D; Kern DH; Waldman SR; Pilch YH Int J Cancer; 1975 Jan; 15(1):116-31. PubMed ID: 1079201 [TBL] [Abstract][Full Text] [Related]
7. Studies on purification of antibodies against tumor-specific antigens. Park MM Pahlavi Med J; 1978 Jan; 9(1):1-26. PubMed ID: 652378 [TBL] [Abstract][Full Text] [Related]
8. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Herberman RB; Nunn ME; Holden HT; Lavrin DH Int J Cancer; 1975 Aug; 16(2):230-9. PubMed ID: 1080480 [TBL] [Abstract][Full Text] [Related]
9. Studies on chemically induced tumors in rats: I. Heterogeneity of tumor cells and establishment of syngeneic, tumor-specific cytotoxic T cell clones. Binz H; Fenner M; Wigzell H Experientia; 1983 Jan; 39(1):39-47. PubMed ID: 6600685 [TBL] [Abstract][Full Text] [Related]
10. Correlation between concanavalin A agglutinability and cytotoxic sensitivity to antiserum against tumor-associated antigen in rat fibrosarcoma cells. Moriuchi T; Gotohda E; Kodama T; Hosokawa M; Kobayashi H J Natl Cancer Inst; 1979 Mar; 62(3):579-83. PubMed ID: 283287 [TBL] [Abstract][Full Text] [Related]
11. Syngeneic antitumour antibodies in rats: clearance of cell-bound antibody in vivo and in vitro. Dean CJ; Hobbs SM; Hopkins JU; North SM; Styles JM Br J Cancer; 1982 Aug; 46(2):190-7. PubMed ID: 7150472 [TBL] [Abstract][Full Text] [Related]
12. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence. Jones DB; Moore M Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783 [TBL] [Abstract][Full Text] [Related]
13. Development of a simplified isotopic antiglobulin assay for the study of tumor-specific antibody. Burdick JF; Wells SA; Cohen AM; Ketcham AS J Surg Res; 1973 Mar; 14(3):200-6. PubMed ID: 4540803 [No Abstract] [Full Text] [Related]
14. A highly sensitive and reproducible microcytotoxicity assay for demonstrating cytotoxic antibodies to cell surface antigens. Hellström I; Brown JP; Klitzman JM; Hellström KE J Immunol Methods; 1978; 22(3-4):369-81. PubMed ID: 681761 [TBL] [Abstract][Full Text] [Related]
15. In vivo growth and antigenic properties of a rat sarcoma induced by Moloney sarcoma virus. Jones JM; Jensen F; Veit B; Feldman JD J Natl Cancer Inst; 1974 Jun; 52(6):1771-7. PubMed ID: 4134500 [No Abstract] [Full Text] [Related]
16. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity. Epstein LB; Knight RA Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852 [TBL] [Abstract][Full Text] [Related]
17. Serologic identification of multiple tumor-associated antigens on murine sarcomas. Parker GA; Rosenberg SA J Natl Cancer Inst; 1977 May; 58(5):1303-9. PubMed ID: 67211 [TBL] [Abstract][Full Text] [Related]
18. Evidence for two factors in sera of tumor-immunized mice which induce specific lymphoid cell-dependent cytotoxicity: IgG2 and a rapidly appearing factor not associated with IgG or IgM. Pollack SB; Nelson K Int J Cancer; 1975 Aug; 16(2):339-46. PubMed ID: 1150357 [TBL] [Abstract][Full Text] [Related]
19. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system. Harada M; Pearson G; Redmon L; Winters E; Kasuga S J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675 [TBL] [Abstract][Full Text] [Related]
20. Induction or elimination of tumor-specific immunity against a chemically-induced rat tumor using auto-anti-idiotypic immunity. Binz H; Meier B; Wigzell H Int J Cancer; 1982 Apr; 29(4):417-23. PubMed ID: 6806201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]